# Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

> **NCT03510988** · NA · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 14 (actual)

## Conditions studied

- Newly Diagnosed Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Hybrid breast FDG PET/MRI

## Key facts

- **NCT ID:** NCT03510988
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-15
- **Primary completion:** 2020-03-04
- **Final completion:** 2022-03-04
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Temporarily paused per study team for interim data review.
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03510988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03510988, "Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03510988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*